Keyphrases
P21Cip1
100%
Peroxisome Proliferator-activated Receptor
100%
Epithelial Cell Line
100%
Sulindac Sulfide
100%
Prostate Epithelial Cells
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
42%
Growth Inhibition
28%
PNT1A
28%
Receptor Antagonist
28%
Peroxisome Proliferator-activated Receptor Agonists
28%
Overexpression
14%
Small Interfering RNA (siRNA)
14%
Cyclin-dependent Kinase Inhibitor
14%
Sulfide Treatment
14%
Immunology and Microbiology
Upregulation
100%
Peroxisome
100%
Prostate
100%
Epithelial Cell Line
100%
Growth Inhibition
22%
Agonist
22%
Cycline
11%
Cell Line
11%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Sulindac Sulfide
100%
Non-Steroidal Anti-Inflammatory Drug
50%
Malignant Neoplasm
33%
PPAR Agonist
33%
Peroxisome Proliferator Activated Receptor Antagonist
33%
Small Interfering RNA
16%
Cyclin Dependent Kinase Inhibitor
16%